Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2915 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation?

Marques A, Fantini ML, Morand D, Pereira B, Derost P, Ulla M, Debilly B, Lemaire JJ, Durif F.

Sleep Med. 2015 May;16(5):583-8. doi: 10.1016/j.sleep.2014.11.020.

0

0

0

PUBMED

Thinking about motor fluctuations: An examination of metacognitions in Parkinson's disease.

Fernie BA, Spada MM, Ray Chaudhuri K, Klingelhoefer L, Brown RG.

J Psychosom Res. 2015 Dec;79(6):669-73. doi: 10.1016/j.jpsychores.2015.05.001.

0

0

0

PUBMED

Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.

Robakis D, Fahn S.

CNS Drugs. 2015 Jun;29(6):433-41. doi: 10.1007/s40263-015-0249-8. Review.

0

0

0

PUBMED

Concomitant fragile X-associated tremor ataxia syndrome and Parkinson's disease: a clinicopathological report of two cases.

De Pablo-Fernandez E, Doherty KM, Holton JL, Revesz T, Djamshidian A, Limousin P, Bhatia KP, Warner TT, Lees AJ, Ling H.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):934-6. doi: 10.1136/jnnp-2014-309460. No abstract available.

0

0

0

PUBMED

Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review.

Lenka A, Jhunjhunwala KR, Saini J, Pal PK.

Parkinsonism Relat Disord. 2015 Jul;21(7):683-91. doi: 10.1016/j.parkreldis.2015.04.005. Review.

0

0

0

PUBMED

Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease.

Rossi M, Perez-Lloret S, Millar Vernetti P, Drucaroff L, Costanzo E, Ballesteros D, Bril A, Cerquetti D, Guinjoan S, Merello M.

Mov Disord. 2015 Aug;30(9):1275-9. doi: 10.1002/mds.26276.

0

0

0

PUBMED

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.

Dehay B, Bourdenx M, Gorry P, Przedborski S, Vila M, Hunot S, Singleton A, Olanow CW, Merchant KM, Bezard E, Petsko GA, Meissner WG.

Lancet Neurol. 2015 Aug;14(8):855-66. doi: 10.1016/S1474-4422(15)00006-X. Review.

0

0

0

PUBMED

Temporal Lobe and Frontal-Subcortical Dissociations in Non-Demented Parkinson's Disease with Verbal Memory Impairment.

Tanner JJ, Mareci TH, Okun MS, Bowers D, Libon DJ, Price CC.

PLoS One. 2015 Jul 24;10(7):e0133792. doi: 10.1371/journal.pone.0133792.

0

0

0

PUBMED

Chemical Exchange Saturation Transfer MR Imaging is Superior to Diffusion-Tensor Imaging in the Diagnosis and Severity Evaluation of Parkinson's Disease: A Study on Substantia Nigra and Striatum.

Li C, Wang R, Chen H, Su W, Li S, Zhao X, Zhou J, Qiao J, Lou B, Song G, Chen M.

Front Aging Neurosci. 2015 Oct 19;7:198. doi: 10.3389/fnagi.2015.00198.

0

0

0

PUBMED

α-Synuclein and nonhuman primate models of Parkinson's disease.

Vermilyea SC, Emborg ME.

J Neurosci Methods. 2015 Nov 30;255:38-51. doi: 10.1016/j.jneumeth.2015.07.025. Review.

0

0

0

PUBMED

Epigenetic mechanisms in Parkinson's disease.

Feng Y, Jankovic J, Wu YC.

J Neurol Sci. 2015 Feb 15;349(1-2):3-9. doi: 10.1016/j.jns.2014.12.017. Review.

0

0

0

PUBMED

Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells.

Oliveira LM, Falomir-Lockhart LJ, Botelho MG, Lin KH, Wales P, Koch JC, Gerhardt E, Taschenberger H, Outeiro TF, Lingor P, Schüle B, Arndt-Jovin DJ, Jovin TM.

Cell Death Dis. 2015 Nov 26;6:e1994. doi: 10.1038/cddis.2015.318.

0

0

0

PUBMED

Dietary modifications in Parkinson's disease: A neuroprotective intervention?

Shah SP, Duda JE.

Med Hypotheses. 2015 Dec;85(6):1002-5. doi: 10.1016/j.mehy.2015.08.018.

0

0

0

PUBMED

Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils.

Gao X, Carroni M, Nussbaum-Krammer C, Mogk A, Nillegoda NB, Szlachcic A, Guilbride DL, Saibil HR, Mayer MP, Bukau B.

Mol Cell. 2015 Sep 3;59(5):781-93. doi: 10.1016/j.molcel.2015.07.012.

0

0

0

PUBMED

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial.

Ferreira JJ, Lees A, Rocha JF, Poewe W, Rascol O, Soares-da-Silva P; Bi-Park 1 investigators..

Lancet Neurol. 2015 Dec 22. pii: S1474-4422(15)00336-1. doi: 10.1016/S1474-4422(15)00336-1. [Epub ahead of print]

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy